Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar PustulosisSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Stomatognathic Diseases, mouth disorder, palmoplantar pustulosis, periodontal disorder, periodontitis, periodontitis, aggressive 1, psoriasis, skin disorderRecruitingPhase 32026-08-27NCT07219420

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
UCB Biopharma SRL30

91 results · Page 1 of 4

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Ppp001 20022HangzhouChina1
Ppp001 20104SeoulSouth Korea1
Ppp001 20136TianjinChina1
Ppp001 20137ChengduChina1
Ppp001 20184ShenzhenChina1
Ppp001 20193HangzhouChina1
Ppp001 20208Seongnam-siSouth Korea1
Ppp001 20211Bucheon-siSouth Korea1
Ppp001 20214BusanSouth Korea1
Ppp001 20215GwangjuSouth Korea1
Ppp001 20216SeoulSouth Korea1
Ppp001 20220SeoulSouth Korea1
Ppp001 20311GuangzhouChina1
Ppp001 20313GuangzhouChina1
Ppp001 20344JinanChina1
Ppp001 20345ShanghaiChina1
Ppp001 20350ChongqingChina1
Ppp001 20351SeoulSouth Korea1
Ppp001 20352ChengduChina1
Ppp001 20353YinchuanChina1
Ppp001 20354SeoulSouth Korea1
Ppp001 20355JinanChina1
Ppp001 20356Xi'anChina1
Ppp001 20357BeijingChina1
Ppp001 20359SeoulSouth Korea1